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Introduction
Acute inflammation is a critically important pathophysiological 
response to a local stimulus (e.g., bacterial infection) characterized 
by local tissue infiltration of neutrophils and tissue swelling (ede-
ma). These responses typically begin within minutes after a stim-
ulus and collectively support the activation of essential immuno-
regulatory, proinflammatory, and proresolution pathways required 
for effective host defense and tissue repair. Excessive and/or inap-
propriately triggered neutrophil migration and increased vascular 
leakage can also be the underlying cause of a vast range of acute 
and chronic inflammatory disorders, such as acute lung injury and 
rheumatoid arthritis, and are as such well-established antiinflam-
matory therapeutic targets (1, 2). Central to regulation of these 
responses are endothelial cells (ECs) that line the inner aspect 
of all blood vessels and provide the principal barrier to migrating 
immune cells and blood-borne macromolecules. With respect to 
neutrophil trafficking, ECs provide critical proadhesive and oth-
er effector molecules that facilitate a cascade of neutrophil-EC 
interactions, such as neutrophil rolling, firm arrest, and luminal 
crawling. These events that are generally considered to be prereq-
uisite to breaching of the endothelium (3). Transendothelial cell 
migration (TEM) is supported by an array of EC junctional mole-
cules, most notably PECAM-1 (CD31), members of the junctional 
adhesion molecule (JAM) family, VE-cadherin, and others (3–5). 
In addition, we recently demonstrated the importance of retain-
ing directional cues within EC junctions in facilitating luminal-to- 
abluminal neutrophil breaching of the endothelium (6).
With respect to vascular leakage, under basal conditions the 
microvascular endothelium has a low permeability to plasma pro-
teins, and as such establishes an oncotic gradient that opposes 
the vascular hydrostatic pressure that would otherwise excessive-
ly move water and solutes into the tissue. This situation rapidly 
changes in inflammation, enabling immediate supply of plasma 
proteins (e.g., complement components and Abs) to injured or 
infected organs through increased permeability of the vascular 
endothelium (7). Leakage of macromolecules in inflammation 
largely occurs via a paracellular route involving loosening of EC 
junctions (5, 7, 8) mediated via actinomyosin-based contraction 
of ECs and destabilization of junctional contacts. The latter most 
notably involves downregulation of the adhesive functions of 
VE-cadherin (5, 8), with inflammation-induced increased vascular 
permeability being associated with elevated tyrosine phosphoryla-
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inflammatory responses induced by local injections of leukotriene 
B4 (LTB4) and IL-1β and by a local pathophysiological insult of isch-
emia/reperfusion (IR) injury (all within 2 to 4 hours). Although 
these acute reactions elicited significant and comparable levels of 
total neutrophil infiltration into tissues within the overall test peri-
ods, as compared with control responses (Figure 1B), marked and 
rapid increased vascular leakage was only detected in tissues stim-
ulated with LTB4 and IR (Figure 1C). Of note, over time, hyperper-
meability reactions were associated with uptake of tissue-infiltrat-
ed dextran by perivascular cells (Figure 1A) but these regions were 
excluded from the image analysis process.
Most importantly, in contrast to the normal neutrophil TEM 
observed in IL-1β–stimulated tissues (i.e., neutrophils breach-
ing EC junctions in a luminal-to-abluminal direction and with-
out pause; Figure 1D and Supplemental Video 2), inflammatory 
reactions that increased vascular leakage were associated with 
the occurrence of neutrophil rTEM (Supplemental Video 3). Spe-
cifically, in LTB4- and IR-stimulated tissues, and in line with our 
previous reports (14, 15), a significant proportion of neutrophils 
that initiated TEM by extending protrusions through EC junc-
tions rapidly retracted their cell body, exhibited reverse motility 
through EC junctions, and ultimately returned to the blood circu-
lation (Figure 1D). This mode of neutrophil TEM accounted for 
approximately 20%–40% of all TEM events driven by LTB4 and IR 
but was rarely seen in IL-1β–stimulated tissues (<5%) (Figure 1E). 
Using the IR reaction to analyze the onset of this phenomenon, 
we noted that approximately 62% of the rTEM events occurred 
within the first 10 minutes of the reperfusion phase (Figure 1F). 
In contrast, normal neutrophil TEM, as indicated via neutrophil 
accumulation in the perivascular tissue, was more sustained and 
continued to develop over the 2-hour reperfusion period analyzed 
(data not shown). Of significance, although a close temporal asso-
ciation was observed between dextran leakage and frequency of 
neutrophil rTEM, the former exhibited an earlier onset (i.e., with-
in less than 5 minutes after reperfusion; Figure 1F). This raised 
the possibility that increased EC permeability can influence the 
directionality of neutrophil TEM, prompting us to investigate the 
impact of vascular leakage–enhancing stimuli, histamine and 
VEGF-A164 (VEGF), on rTEM.
In agreement with previously published reports (16, 17), top-
ical application of histamine to exteriorized cremaster muscles 
promoted neutrophil rolling but failed to induce neutrophil firm 
arrest or transmigration (Supplemental Figure 1, A–C). Similarly, 
topical application of histamine to exteriorized IL-1β–stimulated 
cremaster muscles caused no significant increase in neutrophil 
adhesion or transmigration beyond that seen with IL-1β alone 
(Supplemental Figure 1D and Figure 2A). As anticipated, topical 
histamine induced a marked vascular leakage response in IL-1β–
treated tissues as compared with tissues treated with just IL-1β 
or PBS (Figure 2, B and C, and Supplemental Video 4); however, 
most intriguingly, it promoted a significant frequency of neutro-
phil rTEM events (~20%; Figure 2D and Supplemental Video 4). 
Similarly, although i.v. VEGF induced a notable vascular leakage 
response in mice treated with local IL-1β (Supplemental Figure 1E) 
without affecting total neutrophil infiltration (Supplemental Figure 
1F), it caused a dramatic increase in frequency of neutrophil rTEM 
(~25%; Figure 2D). Furthermore, in animals treated with IL-1β plus 
tion of components of the VE-cadherin–catenin complex (5, 9). Of 
particular significance, investigations using knockin mice express-
ing specific point mutations in VE-cadherin tyrosine residues (i.e., 
VEC-Y685F and VEC-Y713F) have categorically identified distinct 
molecular mechanisms in governing the passage of neutrophils 
and macromolecules through EC junctions (9). These findings 
are in line with early seminal works that definitively uncoupled 
in a temporal and spatial manner leukocyte extravasation from 
increased vascular permeability (10, 11).
Despite this, the close association of stimulated neutrophil 
transmigration and vascular permeability has historically attract-
ed much attention toward their potential interplay, and indeed, 
it is now generally accepted that neutrophils can promote micro-
vascular leakage in the early stages of an acute inflammatory 
response (12, 13). However, whether vascular permeability can 
regulate neutrophil migration remains poorly investigated and 
is contentious. To address this fundamental element of acute 
inflammation we used confocal intravital microscopy (IVM) to 
simultaneously analyze vascular leakage and neutrophil traffick-
ing in inflamed tissues. Increased microvascular leakage did not 
influence the overall magnitude of neutrophil infiltration into tis-
sues over several hours. Surprisingly, however, leaky microvessels 
promoted a rapid and significant frequency of neutrophil reverse 
TEM (rTEM) (~20%–40%) in the early phases of hyperpermeabil-
ity reactions. This aberrant behavior was caused by an immediate 
increase in diffusion of interstitial chemokines into the vascular 
lumen, a response that disrupted the correct localization of che-
motactic cues within the venular wall niche. Furthermore, through 
development of an in vivo cell labeling method, we provide direct 
evidence for the ability of rTEM neutrophils that have stemmed 
from an inflammatory vascular leakage site to traffic to the lungs. 
Functionally, rTEM neutrophils were activated, and their pres-
ence within the pulmonary vasculature was aligned with sites 
of vascular injury, suggesting a pathological role for this subset 
of neutrophils. Collectively, by finding that local microvascular 
leakage induction facilitates movement of interstitial chemokines 
through EC junctions and entry into the vascular lumen, we have 
discovered an additional mechanism for promotion of neutrophil 
rTEM in vivo. Importantly, our findings directly link this cascade 
of events with the capacity of local hyperpermeability reactions to 
elicit remote organ damage.
Results
Leaky venules support neutrophil rTEM. To directly investigate 
potential associations between neutrophil trafficking and micro-
vascular permeability, inflamed mouse cremaster muscles were 
analyzed for neutrophil breaching of EC junctions and microvascu-
lar leakage in real time and in 3D (i.e., 4D) by confocal IVM. Briefly, 
the model employs LysM-EGFP-ki mice in conjunction with in vivo 
labeling of EC junctions using locally applied, nonblocking Alexa 
Fluor 647–labeled (AF647-labeled) anti-CD31 mAb (14). Neutro-
phil TEM was analyzed through tracking of GFPbright neutrophils, 
and microvascular leakage was quantified by measuring intersti-
tial accumulation of intravenously injected plasma protein tracer 
TRITC-dextran (MW ~75 kDa) (Figure 1A and Supplemental Video 
1; supplemental material available online with this article; https://
doi.org/10.1172/JCI133661DS1). In initial studies we analyzed 
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phil TEM, with the induction of leakage emphatically affecting the 
directional migration of neutrophils through EC junctions.
Genetic defect in microvascular leakage suppresses neutrophil 
rTEM. To further investigate the causal link between increased 
microvascular leakage and disrupted neutrophil TEM, we took 
histamine, maximal neutrophil rTEM was again detected rapidly 
after topical application of histamine (~80% within 20 minutes), in 
line with the rapid stimulated vascular leakage (Figure 2E). Collec-
tively, the present findings demonstrate a previously unappreciat-
ed link between induction of vascular leakage and aberrant neutro-
Figure 1. Hyperpermeability inflammatory reactions are associated with neutrophil reverse transendothelial migration. Cremaster muscles of LysM-
EGFP-ki mice were subjected to IL-1β– or LTB4-induced inflammation (120 and 30 minutes, respectively), or to IR injury (40 minutes ischemia + 1–2 hours 
reperfusion) and analyzed by confocal IVM. PBS-treated or sham-operated animals were used as control. AF647-labeled anti-CD31 mAb was injected i.s. to 
visualize EC junctions (red) and i.v. fluorescent (75 kDa) TRITC-dextran was used to visualize vascular leakage (blue pseudocolor intensity). (A) Represen-
tative images of IR-stimulated cremasteric venules (see Supplemental Video 1), showing the development of an inflammatory response in terms of neu-
trophil migration (green GFPbright neutrophils; top panels) and dextran leakage (blue; bottom panels) at the indicated times after reperfusion. Scale bars: 20 
μm. (B) Total neutrophil extravasation (n = 5–12 mice/group). (C) Time course of dextran accumulation in the perivascular region of a selected postcapillary 
venule (n = 3–10 mice/group). (D) Representative images of an IR-stimulated cremasteric postcapillary venule at different times after reperfusion (see 
Supplemental Videos 2 and 3) illustrating a normal neutrophil TEM (top) and a reverse TEM (bottom) event. Luminal and cross-sectional views with arrows 
indicating the direction of motility of the indicated neutrophil. Scale bars: 5 μm. (E) Frequency of neutrophil reverse TEM events in relation to total TEM 
events of 20.7 ± 2.1 (IL-1β), 31.3 ± 5.9 (LTB4), and 15 ± 2.4 (IR injury) per 300-μm venular segment within 2-hour microscopy periods (mean ± SEM, n = 6–9 
mice/group). (F) Temporal association of dextran leakage and cumulative frequency of neutrophil reverse TEM (n = 4 mice). Data are mean ± SEM (each 
symbol represents 1 mouse/independent experiment). Statistically significant differences from PBS-treated (B) or IL-1β–treated (E) mice are indicated by 
**P < 0.01; ***P < 0.001, 1-way ANOVA followed by Bonferroni’s post hoc test.
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VEC-WT mice (Figure 3E). Together, our results provide compel-
ling evidence for the ability of increased vascular leakage to disrupt 
luminal-to-abluminal motility of neutrophils through EC junctions 
resulting in neutrophil rTEM back into the vascular lumen.
Microvascular leakage promotes trafficking of interstitial chemo-
kines into the bloodstream. We next explored the mechanism 
through which vascular leakage induction promotes disrupt-
ed directionality of neutrophil TEM. Because our earlier works 
identified reduced EC junctional expression of JAM-C as a driv-
er of incomplete and reverse modes of neutrophil TEM (14, 15), 
this possibility was evaluated in the context of vascular leakage. 
However, local histamine, IL-1β, or the combination of both medi-
ators had no impact on expression of EC JAM-C (Supplemental 
Figure 2). In considering alternative mechanisms, we hypoth-
esized that elevated microvascular permeability may alter the 
local chemotactic gradient across venular walls. To explore this 
notion, because IL-1β is an effective inducer of a potent neutrophil 
chemokine CXCL1 (18, 19), we sought to investigate the impact 
of increased vascular leakage on generation and localization of 
CXCL1 in IL-1β–stimulated tissues.
IL-1β stimulation of WT cremaster muscles led to a robust 
increase in tissue and plasma CXCL1, as compared with PBS-treat-
advantage of a knockin mouse model that expresses a Y685F 
mutant of VE-cadherin (VEC-Y685F) and shows reduced vascu-
lar leakage but normal neutrophil extravasation (9). Knockin mice 
expressing wild-type (WT) VE-cadherin (VEC-WT) were used as 
controls. To facilitate simultaneous quantification of neutrophil 
TEM dynamics and vascular leakage, chimeric mice were gener-
ated through adoptive transfer of bone marrow from LysM-EGFP-
ki donor mice into irradiated VEC-WT and VEC-Y685F recipients 
(Figure 3A). Using the model of local IL-1β plus histamine, VEC-
Y685F chimeric mice showed reduced (~26%) interstitial dextran 
accumulation (Figure 3, B and C) with no significant change in total 
neutrophil extravasation over 2 hours (Figure 3D), as compared 
with responses detected in chimeric VEC-WT controls. These 
results are in line with the findings of Wessel and colleagues using 
the Miles assay in which 36% suppression of histamine-induced 
vascular leakage was detected in the dorsal skin of VEC-Y685F 
mice (9). Of note, in agreement with our previous results (Figure 
2D), IL-1β plus histamine caused a substantial frequency of neutro-
phil rTEM (~22%; Figure 3E) in VEC-WT chimeric mice. However, 
mice harboring the mutant form of VE-cadherin exhibited a signifi-
cantly reduced frequency of this response (down to ~10%), culmi-
nating in approximately 55% inhibition of rTEM as compared with 
Figure 2. Induction of microvascular leakage promotes neutrophil reverse transendothelial migration. Cremaster muscles of LysM-EGFP-ki mice were 
subjected to IL-1β–induced inflammation for 120 minutes and analyzed by confocal IVM. AF647-labeled anti-CD31 mAb (i.s.) and 75-kDa TRITC-dextran 
(i.v.) were used to visualize EC junctions (red) and vascular leakage (blue pseudocolor intensity), respectively. Mice were superfused with histamine (30 
μM) or injected i.v. with VEGF (4 μg) 2 hours after IL-1β stimulation. (A) Total neutrophil extravasation (n = 4–5 mice/group). (B) Representative images of a 
postcapillary venular segment subjected to IL-1β plus histamine stimulation at different time points after application of histamine, illustrating neutrophil 
TEM and dextran leakage responses (see Supplemental Video 4). Scale bars: 20 μm. (C) Time course of dextran accumulation in the perivascular region of a 
selected postcapillary venule (n = 3–9 mice/group). (D) Frequency of neutrophil reverse TEM events in relation to total TEM events of 15.2 ± 2.4 (IL-1β), 19.8 
± 2.9 (IL-1β + hist), and 21 ± 3.6 (IL-1β + VEGF) per 300-μm venular segment within 2-hour microscopy periods (mean ± SEM, n = 4–10 mice/group). (E) Tem-
poral association of dextran leakage and cumulative frequency of neutrophil reverse TEM (n = 7–9 mice/group). Data are represented as mean ± SEM (each 
symbol represents 1 mouse/independent experiment). Statistically significant differences from PBS-treated (A) or IL-1β–treated (D) mice are indicated by 
*P < 0.05; **P < 0.01; ***P < 0.001, 1-way ANOVA followed by Bonferroni’s post hoc test.
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high-MW (75 kDa) TRITC-dextran. Superfusion of exteriorized 
cremaster muscles with 10-kDa AF488-dextran (for 10 minutes) 
led to its rapid and sustained accumulation in the extravascular 
space surrounding blood vessels (Figure 4, E and F, and Supple-
mental Video 5). Topical application of histamine caused imme-
diate leakage of blood-circulating 75-kDa TRITC-dextran into the 
interstitium (Figure 4, E and G, and Supplemental Video 5), con-
firming induction of vascular leakage. Importantly, this effect was 
associated with rapid (<5 minutes) disappearance of the 10-kDa 
AF488-dextran signal from the perivascular space, as compared 
with tissues treated with topical vehicle (Figure 4, E–G). Further-
more, in mice treated with topical histamine, a significant level of 
10-kDa AF488-dextran was detected in plasma (Figure 4H).
Collectively, these results demonstrate that under conditions 
of enhanced vascular permeability, a small-MW protein can dif-
fuse from the interstitium into the bloodstream against an advec-
tive flow in the opposite direction. As seemingly unexpected, fur-
ther validation of these experimental findings were sought through 
mathematical modeling. Briefly, as the molecular flux across 
the vessel wall is determined by a combination of diffusive and 
advective transport, for a small-MW protein in the extravascular 
ed mice (Figure 4, A–D). Although locally injected histamine or 
i.v. VEGF had no significant effect on IL-1β–induced tissue levels 
of CXCL1, they elevated the associated plasma levels of CXCL1 
(Figure 4, A–D). Of note, the vasoactive agents on their own did 
not induce either tissue or plasma CXCL1 (Figure 4, A–D). Simi-
larly, as found with IL-1β, TNF stimulation of cremaster muscles 
increased tissue and plasma CXCL1, with the latter being further 
elevated after local administration of histamine (Figure 4, A and 
B). In addition, increased tissue and plasma CXCL1 were detected 
in mice subjected to the hyperpermeability-inducing cremasteric 
IR injury (Supplemental Figure 3). These results imply that vas-
cular permeability–enhancing stimuli can promote the traffick-
ing of endogenously generated CXCL1 from the tissue into the 
bloodstream. To directly investigate this possibility, we asked a 
general but fundamental question: can an extravascular protein, 
comparable to the size of a chemokine (~8 kDa), traffic into the 
bloodstream through hyperpermeable leaky microvessels? To 
address this, we examined by confocal IVM the localization of 
topically applied small-MW (10 kDa) AF488-dextran in control 
and histamine-treated IL-1β–stimulated cremaster muscles. Here, 
vascular leakage was simultaneously quantified using i.v.-injected 
Figure 3. Chimeric VEC-Y658F mice exhibit reduced microvascular leakage induction and neutrophil reverse TEM. (A) Generation of chimeric mice 
exhibiting LysM-EGFP-ki hematopoietic cells within VEC-WT or VEC-Y658F recipients. (B) Representative confocal IVM images of postcapillary venular seg-
ments (stained with anti-CD31; red) subjected to IL-1β plus histamine stimulation at 2 time points after application of histamine in chimeric VEC-WT and 
VEC-Y658F mice, illustrating dextran leakage (blue pseudocolor intensity). Scale bars: 10 μm. (C) Time course of dextran accumulation in the perivascular 
region of selected IL-1β–stimulated postcapillary venules in VEC-WT and VEC-Y658F chimeric mice after topical application of histamine (n = 6–12 mice per 
group). (D) Total neutrophil extravasation (n = 5–11 mice per group). (E) Frequency of neutrophil reverse TEM events in relation to total TEM events of 16.6 ± 
2.1 (VEC-WT) and 19.2 ± 3.1 (VEC-Y685F) per 300-μm venular segment within 2-hour microscopy periods (mean ± SEM, n = 5–11 mice). Data are represented 
as mean ± SEM (each symbol represents 1 mouse/independent experiment). Indicated statistical differences are shown by *P < 0.05, 2-tailed Student’s t 
test. NS, not significant.
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compartment (e.g., 10-kDa dextran or a chemokine) to enter the 
blood circulation, the diffusive flux from tissue to blood must be 
high enough to overcome the opposing advective flux (Figure 4I). 
This ratio is defined by the Péclet number (Pe) (Figure 4J). If the Pe 
is substantively less than 1, then there can be diffusion against an 
advective flow of fluid. If the Pe is more than 1, then diffusion can-
not effectively oppose filtration — in other words, for a molecule 
to diffuse against a flow of fluid Pe needs to be less than 1. Using 
previously published values for the hydraulic conductivity proper-
ties of ECs, and known diffusion coefficients, the Pe number for a 
10-kDa dextran in cremaster muscle microvessels is calculated to 
be approximately 0.8 under normal conditions (Supplemental Fig-
ure 4). Such a scenario would allow some diffusion of interstitial 
protein into the vascular lumen, in line with our experimental data 
(Figure 4H). However, under conditions of increased vascular per-
meability (e.g., as induced by local histamine) this falls substan-
tially to values at which diffusion dominates advective flux (i.e., 
Pe < 0.3; Figure 4I and Supplemental Figure 4). This modeling of 
the molecular flux across cremasteric venular walls supports our 
experimental data and provides additional endorsement for the 
concept that vascular hyperpermeability can facilitate the traffick-
ing of extravascular small molecules into the vascular lumen.
We next directly assessed the capacity of an interstitial 
chemokine to engage with EC junctions and to leak from the tis-
sue into the bloodstream after vascular permeability induction. 
For this purpose, we analyzed the localization of human CXCL8 
(hCXCL8) in relation to ECs, when locally applied to IL-1β–stimu-
lated cremaster muscles, in the presence or absence of histamine. 
Although in control tissues the chemokine was modestly aligned 
with the endothelium, this was significantly elevated after local 
application of histamine, most notably in relation to EC junctions 
(Figure 5, A and B). Furthermore, while locally injected hCXCL8 
could be detected in plasma of mice treated with IL-1β only, this 
response was significantly increased (~42%) in mice treated with 
IL-1β plus histamine (Figure 5C). A similar increase in plasma 
levels of locally injected hCXCL8 was noted in mice treated with 
IL-1β plus VEGF as compared with animals treated with IL-1β 
plus vehicle (Supplemental Figure 5). Furthermore, VEC-Y685F 
mutant mice that exhibit a defect in vascular permeability induc-
tion (ref. 9 and Figure 3, B and C) showed reduced plasma levels 
of hCXCL8 as compared with levels detected in control VEC-WT 
animals (Figure 5D). The link between vascular permeability 
induction and tissue-to-blood chemokine movement was further 
investigated through the use of blocking anti–VE-PTP and anti–
VE-cadherin Abs. Specifically, an anti–VE-PTP Ab that inhibits 
vascular permeability induction through activation of Tie2 (20, 
21) (a) significantly suppressed histamine-induced vascular leak-
age in the mouse cremaster muscle (Supplemental Figure 6A), 
and (b) significantly reduced plasma levels of locally adminis-
tered hCXCL8 in mice treated with IL-1β plus histamine, as com-
pared with control Ab–treated mice (Figure 5E). Animals treated 
with the anti–VE-PTP Ab also showed reduced plasma levels of 
endogenously generated CXCL1, as compared with levels detect-
ed in control Ab–treated mice (Supplemental Figure 6B). In con-
trast to the inhibitory effects of the anti–VE-PTP Ab, a blocking 
anti–VE-cadherin mAb (clone BV13) (22) that promoted vascular 
leakage induction in the mouse cremaster muscle (Supplemental 
Figure 6, C and D) enhanced plasma levels of locally administered 
hCXCL8 as compared with levels detected in mice treated with a 
control mAb (anti-CD31) (Figure 5F).
Together, through experimental and mathematical modeling, 
we provide compelling evidence to show that the loosening of EC 
junctions during increased vascular permeability can promote the 
mobilization of small-MW proteins from the interstitial tissue to 
the bloodstream and thus influence the compartmentalization of 
extravascular chemokines.
Luminal CXCL1 promotes neutrophil rTEM. We next investigat-
ed the functional impact of increased plasma CXCL1 on neutrophil 
TEM. For this purpose, 2 hours after stimulation of cremaster mus-
cles with IL-1β, LysM-EGFP-ki mice were injected i.v. with a blocking 
anti-CXCL1 mAb before topical application of histamine. Although 
at the dose employed i.v. administration of the anti-CXCL1 mAb 
had no impact on plasma protein leakage or total neutrophil extrav-
asation (Figure 6, A and B), this intervention significantly reduced 
the frequency of neutrophil rTEM events (~60% inhibition), as 
compared with control Ab–injected mice (Figure 6C). Similarly, sys-
temic CXCL1 blockade had no impact on total neutrophil extravasa-
tion in cremaster muscles subjected to IR insult (Figure 6D) but sup-
pressed neutrophil rTEM in this permeability-enhancing reaction 
(~60% inhibition; Figure 6E). Because this suggested that luminal 
CXCL1 can drive neutrophil rTEM, this was categorically investi-
gated through i.v. injection of exogenous CXCL1 in LysM-EGFP-ki 
mice stimulated locally with IL-1β (2 hours). Within this protocol, 
i.v. CXCL1 promoted a substantial frequency of neutrophil rTEM 
through cremasteric venules (~30%; Figure 6F), whereas as noted 
previously (Figure 1E), local IL-1β on its own did not cause neutro-
phil rTEM (Figure 6F). Collectively, the present results unequivo-
cally demonstrate that vascular CXCL1 can drive neutrophil TEM 
toward the luminal aspect of the endothelium.
Development of a cell labeling strategy for tracking of neutrophil 
rTEM in vivo. Aiming to gain insight into the fate, phenotype, 
Figure 4. Stimulated microvascular leakage induces movement of 
small-molecular-weight proteins into the vascular lumen. (A–D) Cre-
master muscles of WT mice were stimulated with IL-1β or TNF for 2 hours 
followed by local injection of histamine or i.v. VEGF (or corresponding 
vehicle), for 30 minutes before collection of tissue and plasma sam-
ples for quantification of CXCL1 levels by ELISA. Mice subjected to PBS, 
histamine, or VEGF alone were used as control (n = 4–7 mice/group). (E) 
Representative images of selected IL-1β–stimulated postcapillary venules 
showing movement of i.v. 75-kDa TRITC-dextran (marker of vascular 
leakage; red) and topically applied 10-kDa AF488-dextran (superfused for 
10 minutes; green) after topical superfusion of PBS vehicle (top panels) or 
histamine (30 μM, lower panels; see Supplemental Video 5). Dashed lines 
indicate blood vessel borders. Scale bars: 20 μm. (F and G) Time course 
of 75-kDa TRITC-dextran and 10-kDa AF488-dextran accumulation in the 
perivascular region of selected IL-1β–stimulated postcapillary venules 
after superfusion of vehicle (F, n = 3 mice) or histamine (G, n = 3 mice). 
(H) Quantification of 10-kDa AF488-dextran in plasma samples of mice 
treated as detailed above (n = 3 mice/group). (I and J) Schematic diagram 
and mathematical equation of the Péclet number (Pe) (see Supplemental 
Figure 4). Data are represented as mean ± SEM (each symbol represents 1 
mouse/independent experiment). Statistically significant differences from 
PBS (A–D) or IL1β plus vehicle (H) are indicated by *P < 0.05; **P < 0.01; 
***P < 0.001, between groups as indicated by lines or by #P < 0.05, 1-way 
ANOVA followed by Bonferroni’s post hoc test or 2-tailed Student’s t test. 
NS, not significant.
The Journal of Clinical Investigation R E S E A R C H  A R T I C L E
8 jci.org
er than 10 rTEM neutrophils/inflamed tissue; data not shown). 
Hence, as part of the present study we have developed a labeling 
method that crisply delineates neutrophils that reverse migrate 
within EC junctions and reenter the vascular lumen (Figure 7A). 
The method takes advantage of the strong affinity of streptavidin 
for biotin and our observation that locally applied streptavidin is 
retained within the cremaster muscle tissue and does not move 
into the systemic circulation, even under conditions of increased 
vascular permeability (Supplemental Figure 7A). Initial experi-
ments applied this labeling method to staining of neutrophils in 
IL-1β–stimulated tissues. Briefly, after local application of IL-1β 
(1.5 hours), LysM-EGFP-ki mice were injected i.v. with biotinylated 
anti-Ly6G mAb, a step that as anticipated selectively labeled over 
99% of all circulating neutrophils (Supplemental Figure 7B). Thir-
and pathophysiological relevance of rTEM neutrophils stemming 
from a local hyperpermeable inflammatory site, we established 
a method for tracking of these cells. Previous studies employing 
zebrafish and murine models of tissue injury have utilized genet-
ically encoded photolabeling protocols to track reverse-migrating 
neutrophils from within injured interstitial tissues back into the 
vascular lumen and into distal organs (23–25). However, as the 
neutrophil reverse migration phenomenon noted in the present 
study is restricted to breaching of the endothelium only, photo-
converting and photoactivation of neutrophils confined within 
tight EC junctions or the thin sub-EC space (<3 μm wide) renders 
such genetic strategies inappropriate for exclusive delineation of 
rTEM cells (e.g., preliminary works with transgenic mice express-
ing the Kaede photoconvertible fluorescence protein tracked few-
Figure 5. Vascular leakage induction promotes trafficking of tissue chemokine through venular walls. Cremaster muscles were injected locally with IL-1β 
(50 ng) and human CXCL8 (hCXCL8, 500 ng) for 1 hour, followed by i.s. injection of vehicle (control) or histamine for an additional 1 hour. (A) Representa-
tive confocal images of postcapillary venules stained for hCXCL8 within an EC (labeled by anti-CD31) isosurface mask with an enlarged image of the boxed 
region. Scale bars: 2 μm. (B) Quantification of hCXCL8 MFI on EC body and junctions (n = 8 mice/group). (C–F) Plasma levels of locally applied hCXCL8 in 
WT mice (C), VEC-WT and VEC-Y685F mice (D), in mice treated with a control or anti–VE-PTP Ab (200 μg, i.v.) (E), or treated with an anti–VE-cadherin mAb 
(i.s. BV13, 100 μg), or a control mAb (nonblocking anti–CD31 mAb, 100 μg) for 3 hours before local administration with hCXCL8 for 1 hour (n = 4–8 mice/
group) (F). Data are represented as mean ± SEM (each symbol represents 1 mouse/independent experiment). Statistically significant differences between 
cell body vehicle versus cell body histamine and EC junction (Jn) vehicle versus Jn histamine groups were analyzed by 1-way ANOVA followed by Bonfer-
roni’s post hoc test (*P < 0.05; **P < 0.01). Differences between the other indicated groups are shown by *P < 0.05; **P < 0.01; ***P < 0.001 analyzed by 
2-way ANOVA followed by Bonferroni’s post hoc test (B and D) or 2-tailed paired (B) or unpaired Student’s t test (C, E, and F). NS, not significant.
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tissues and neutrophil rTEM (Supplemental Figure 8, A and B, as 
compared with Figure 2, A and D) as well as similar neutrophil 
migration velocity within EC junctions and the interstitial tissue 
(Supplemental Figure 8, C and D).
Thus, we have established a cell labeling technique for direct 
tracking of neutrophils that exhibit rTEM in vivo. This method-
ological advancement enables definitive explorations into the 
phenotype and fate of rTEM neutrophils.
rTEM neutrophils disseminate into the systemic and pulmonary 
circulation and exhibit an activated phenotype. Exploiting our label-
ing method, we next investigated the distribution of rTEM neu-
trophils stemming from local hyperpermeability sites. Because 
our confocal IVM studies showed rTEM neutrophils to reenter 
the vascular lumen and rapidly detach from the luminal aspect 
of the endothelium (Supplemental Video 6), we initially sought 
to detect these cells in the systemic circulation. For this purpose, 
using mice subjected to cremasteric stimulation with IL-1β, blood 
samples were taken 2 hours after local administration of histamine 
or vehicle in conjunction with the new biotin-streptavidin labeling 
protocol. Flow cytometric analysis of samples from IL-1β–treated 
mice showed very low levels of streptavidin+ circulating blood 
neutrophils (~0.1%, corresponding to a total of approximately 
800 streptavidin+ neutrophils/mL of blood); this number was sig-
ty minutes later, cremaster muscles were surgically exteriorized 
and tissues were topically superfused with AF647-streptavidin. 
Analysis of tissues by confocal microscopy showed that with this 
protocol luminal neutrophils were GFP+ but streptavidin–, where-
as neutrophils in the sub-EC space and in the interstitial tissue 
were clearly positive for both GFP and streptavidin (Figure 7B). 
We next sought to investigate the ability of this labeling method 
to track rTEM neutrophils during the hyperpermeability reaction 
to IL-1β plus histamine where histamine and AF647-streptavidin 
were simultaneously superfused onto surgically exteriorized tis-
sues. Here, intriguingly we noted that in neutrophils exhibiting 
TEM, leading protrusions in the sub-EC space rapidly became 
intensely streptavidin+ (Figure 7C), resulting in effective labeling 
of all neutrophils that partially or fully breached the endotheli-
um. This included cells that completely breached the venular wall 
and entered the surrounding interstitial tissue as well as cells that 
reverse migrated from within EC junctions or the sub-EC space 
back into the vascular lumen (Figure 7, A–D). Similar results were 
obtained when AF647-streptavidin was injected locally into cre-
master muscles (400 ng for 2 hours) as opposed to being topically 
superfused (Supplemental Figure 7, C and D). Importantly, unla-
beled mice and mice subjected to the biotin-streptavidin label-
ing strategy exhibited similar levels of neutrophil migration into 
Figure 6. Systemic CXCL1 promotes neutrophil reverse TEM. Cremaster muscles of LysM-EGFP-ki mice were stimulated with IL-1β (50 ng for 2 hours) fol-
lowed by topical superfusion of histamine onto exteriorized tissues or subjected to IR injury. Blocking anti-CXCL1 mAb (1 mg/kg), or control IgG, was inject-
ed i.v. 30 minutes before exteriorization of tissues or at the point of tissue reperfusion. (A) Time course of dextran accumulation in the perivascular region 
of selected stimulated postcapillary venules. Tissue dextran accumulation is represented as normalized MFI (n = 4–6 mice per group). (B) Total neutrophil 
extravasation (n = 4–5 mice/group) and (C) frequency of neutrophil reverse TEM events in relation to total TEM events of 14 ± 2 (control mAb) and 20 ± 2.9 
(anti-CXCL1 mAb) per 300-μm venular segment within 2-hour microscopy periods (mean ± SEM, n = 5–6 mice/group). (D) Total neutrophil extravasation  
(n = 3–6 mice/group) and (E) frequency of neutrophil reverse TEM events in relation to total TEM events of 26.7 ± 3.8 (control mAb) and 26 ± 4.3 (anti- 
CXCL1) per 300-μm venular segment within 2-hour microscopy periods (mean ± SEM, n = 3–7 mice/group). (F) Cremaster muscles of LysM-EGFP-ki mice 
were stimulated with IL-1β (50 ng for 2 hours) followed by i.v. injection of murine rCXCL1 (50 ng). Frequency of neutrophil reverse TEM events in relation 
to total TEM events of 16 ± 2.8 (IL-1β) and 12.9 ± 1.8 (IL-1β + CXCL1) per 300-μm venular segment within 2-hour microscopy periods (mean ± SEM, n = 5–7 
mice/group). Data are represented as mean ± SEM (each symbol represents 1 mouse/independent experiment). Statistically significant differences from 
control mAb–treated groups (C and E) or IL-1β–treated tissues (F) are shown by *P < 0.05; ***P < 0.001, 2-tailed Student’s t test.
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vidin+ neutrophils as compared to streptavidin– cells. Streptavidin+ 
blood neutrophils exhibited no significant change in expression 
of L-selectin (CD62L), β1 integrins, ICAM-2, neutrophil elastase 
(NE), or CXCR4 but showed significantly increased expression 
of CD11b, and a low but significant increase in expression of 
ICAM-1 (Supplemental Figure 9A and Figure 8C). Based on such 
an activated phenotype, and as guided by our previous works (14, 
15), we hypothesized that streptavidin+ rTEM neutrophils may 
nificantly increased in blood samples of mice locally stimulated 
with IL-1β plus histamine (~0.4%, corresponding to approximate-
ly 2,800 streptavidin+ neutrophils/mL of blood) (Figure 8, A and 
B). Aligned with the substantive frequency of neutrophil rTEM 
seen in the corresponding reactions (see Figure 2D), these results 
strongly indicated the presence of rTEM neutrophils in the sys-
temic circulation. Focusing on the hyperpermeability reaction to 
IL-1β plus histamine, we next explored the phenotype of strepta-
Figure 7. Development of an in vivo labeling strategy for tracking rTEM neutrophils. (A) Diagram detailing the labeling method. Cremaster muscles of 
LysM-EGFP-ki mice were stimulated with IL-1β (50 ng for 2 hours) followed by an i.v. injection of biotinylated anti-Ly6G (2 μg) to label blood neutrophils at 
t = 90 minutes. The tissues were superfused with histamine (30 μM) or vehicle in conjunction with AF647-streptavidin (1 μg/mL) for 2 hours. (B) Represen-
tative confocal image of an IL-1β–stimulated postcapillary venule illustrating the extent of AF647-streptavidin labeling of neutrophils at different stages of 
trafficking (left panel). Right panels shown enlarged images of the boxed regions and illustrate examples of AF647-streptavidin– luminal, AF647-strepta-
vidin+ sub-EC, and AF647-streptavidin+ interstitial neutrophils. Scale bars: 5 μm. (C) Representative confocal IVM images of a tissue stimulated with 
IL-1β plus histamine (see Supplemental Video 6) illustrating the effective labeling of an rTEM event. The exemplified neutrophil shows that once the cell 
has breached an EC junction, the leading body part in the sub-EC space rapidly becomes AF647-streptavidin+ while the luminal body segment remains 
AF647-streptavidin–. The AF647-streptavidin+ neutrophil can be easily tracked as it migrates in a reverse manner toward the vascular lumen and reenters 
the bloodstream. Luminal and cross-sectional views are shown with the arrows indicating the direction of motility of the indicated neutrophil. Scale bars: 
3 μm. (D) Fluorescence intensity of AF647-streptavidin on neutrophils in the venular lumen, tissue, and cells exhibiting rTEM (n = 4 mice/group) during an 
IL-1β plus histamine reaction. Data are represented as mean ± SEM (each symbol represents 1 mouse/independent experiment). Statistically significant 
differences from luminal neutrophils are shown by **P < 0.01; ***P < 0.001, 1-way ANOVA followed by Bonferroni’s post hoc test.
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with PBS, histamine, or IL-1β showed similar levels of streptavi-
din+ neutrophils (~0.2%), mice stimulated with IL-1β followed 
by histamine for 2 hours showed an enrichment of streptavidin+ 
neutrophils in the pulmonary vasculature (~0.8%) (Figure 8, D 
and E). Increasing the local stimulation period with histamine to 
4 hours resulted in a similar level of streptavidin+ neutrophils in 
be additionally retained within the pulmonary vasculature. To 
address this possibility, we analyzed the percentage and pheno-
type of streptavidin+ neutrophils in pulmonary vasculature wash-
outs of mice subjected to local cremaster muscle stimulations 
with PBS, histamine, IL-1β, or IL-1β plus histamine (2 hours) and 
biotin-streptavidin labeling. Although animals treated locally 
Figure 8. Labeled rTEM neutrophils are present in blood and pulmonary vasculature and show an activated phenotype. (A and B) LysM-EGFP-ki mice 
were subjected to local cremaster muscle stimulation with IL-1β (2 hours) and an i.v. injection of biotinylated anti-Ly6G (2 μg) at t = 90 minutes. The tissues 
were then superfused with histamine (30 μM) or vehicle in conjunction with AF647-streptavidin (1 μg/mL) for 2 hours. Peripheral blood was analyzed 
for the frequency of AF647-streptavidin+ neutrophils. (A) Representative flow cytometry profiles and (B) frequency of AF647-streptavidin+ neutrophils 
(LysM-GFPhiGr-1hi) (n = 6 mice/group). (C–G) WT mice were subjected to cremaster muscle stimulation with IL-1β or PBS for 2 hours followed by i.v. injection 
of biotinylated anti-Ly6G (2 μg) at t = 90 minutes. The mice then received an i.s. injection of AF647-streptavidin (400 ng) coadministered with histamine 
(200 μL of 30 μM solution) or PBS for 2 hours. Peripheral blood and pulmonary vascular washout samples were analyzed by FACS. (C) Expression of indi-
cated markers on AF647-streptavidin+ neutrophils relative to levels on AF647-streptavidin– neutrophils in blood samples collected from mice subjected to 
IL-1β plus histamine, as measured by geometric MFI (gMFI) (n = 5–8 mice/group). (D) Representative flow cytometry profiles and (E) frequency of pulmo-
nary vascular washout AF647-streptavidin+ neutrophils (Gr-1hiCD115–) (n = 4–8 mice/group). (F) Representative FACS histograms and (G) expression of indi-
cated markers on AF647-streptavidin+ neutrophils relative to levels on AF647-streptavidin– neutrophils in pulmonary vascular washout samples collected 
from mice stimulated with IL-1β plus histamine, as measured by gMFI (n = 6–9 mice/group). Data are represented as mean ± SEM (each symbol represents 
1 mouse/independent experiment). Statistically significant differences from IL-1β (B), gMFI of indicated markers of blood AF647-streptavidin– neutrophils 
(C), PBS (E), and gMFI of indicated markers on pulmonary vascular washout AF647-streptavidin– neutrophils (G) are shown by *P < 0.05; **P < 0.01 or by 
indicated comparisons ##P < 0.01, 2-tailed Student’s t test (B, C, and G) or 1-way ANOVA followed by Bonferroni’s post hoc test (E). NS, not significant.
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level of streptavidin+ neutrophils was detected in the bone marrow 
(Supplemental Figure 9, D–G). Together, these results suggest that 
the retention of rTEM neutrophils in the lungs is transient and 
that this subset of cells eventually migrate to the bone marrow. 
blood (~0.42%) but led to a reduced and nonsignificant level in 
the pulmonary vasculature (~0.2%) (Supplemental Figure 9, B and 
C). Interestingly, in mice treated locally with IL-1β followed by 4 
hours of stimulation with histamine, but not 2 hours, a significant 
Figure 9. Accumulation of labeled rTEM neutrophils in lungs is linked with lung injury. The cremaster muscles of LysM-EGFP-ki mice were locally stim-
ulated with IL-1β or PBS (2 hours). Mice were injected i.v. with AF555–anti-CD31 mAb (10 μg), biotin–anti-Ly6G mAb, and fluorescent microspheres (20 nm 
diameter, 9.1 × 1013 beads) at t = 90 minutes to label the vasculature and neutrophils, and to quantify vascular leakage, respectively. To induce and track 
rTEM neutrophils stemming from the cremaster muscles, tissues were additionally stimulated with locally applied histamine or vehicle (PBS) in combina-
tion with Atto425-streptavidin (AT425-Strept, 400 ng) for 120 minutes. The lungs were then analyzed by confocal microscopy. (A) Representative confocal 
images of alveolar capillaries in whole-mount imaged lungs of mice in which the cremaster muscles were locally stimulated as indicated (CD31-labeled 
vessels, red; neutrophils, blue; extravascular beads, green). Scale bars: 20 μm. (B) Lung vascular leakage as quantified by accumulation (MFI) of extravas-
cular beads (n = 4–6 mice/group) and (C) number of AT425-streptavidin+ neutrophils per field of view (n = 4–6 mice per group), in mice subjected to  
indicated cremaster muscle stimulations. (D) Correlation of the number of AT425-streptavidin+ neutrophils and extravascular beads in lung tissues  
(n = 4–6 mice/group). Line indicates linear regression and dashed lines 95% confidence band (Spearman’s r = 0.7). (E) High-magnification images of lung 
sections showing AT425-streptavidin+ neutrophils in close apposition to sites of extravascular fluorescent bead accumulation. Scale bars: 3 μm. (F) Lung 
vascular leakage in close proximity (<60 μm) of AT425-streptavidin– neutrophils or AT425-streptavidin+ neutrophils (n = 6 mice/group). Data are represent-
ed as mean ± SEM (each symbol represents 1 mouse/independent experiment). Statistically significant differences from PBS or indicated group are shown 
by **P < 0.01; ***P < 0.001, and between indicated groups by ##P < 0.01; ###P < 0.001, 1-way ANOVA followed by Bonferroni’s post hoc test (B and C), or 
Spearman’s rank correlation test (D), or paired t test (F). NS, not significant.
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els of total neutrophil recruitment to lungs (~15 neutrophils/field of 
view), a significantly elevated number of streptavidin+ neutrophils 
was detected in lungs of mice subjected to cremaster muscle local 
hyperpermeability (Figure 9C). Furthermore, these studies indi-
cated a significant association between numbers of streptavidin+ 
neutrophils and the extent of increased lung vascular permeability 
(Figure 9D) and a significant association between the presence of 
streptavidin+ neutrophils and sites of pulmonary vascular leakage 
(Figure 9, E and F). Collectively, the findings demonstrate that a 
local hyperpermeability reaction can promote distal organ injury 
by recruitment of rTEM neutrophils (Figure 10).
Discussion
Enhanced microvascular leakage and neutrophil trafficking are 
pivotal features of an acute inflammatory response. Importantly, 
the molecular bases of these events are distinct (9) and there is 
ample evidence to show that neutrophil extravasation in vivo per 
se is not sufficient for increased microvascular leakage (present 
study and refs. 10, 11). Nonetheless, neutrophils, most notably 
when stimulated to adhere by certain chemoattractant mediators 
(27, 28), can secrete a range of permeability-enhancing factors 
(e.g., VEGF, LTA4, HBP, TNF) (12, 13, 29–31). Here we report for 
the first time to our knowledge that increased vascular permeabil-
ity can also impact neutrophil trafficking by reversing the direc-
tional luminal-to-abluminal migration of neutrophils through the 
endothelium. Mechanistically, this was governed by disrupted 
localization of tissue chemokines as induced by the movement of 
chemokines into the vascular lumen through leaky venular walls. 
Crucially, we demonstrate that neutrophils stemming from hyper-
permeability sites reenter the systemic circulation, exhibit an acti-
vated phenotype, and traffic to the lungs where they are present 
at sites of vascular injury. Collectively, through identifying a pre-
viously unreported link between two fundamental components 
of inflammation, our findings extend current understanding of 
pathological inflammation and suggest that targeting local micro-
vascular permeability may provide an effective means of sup-
pressing neutrophil-mediated remote organ damage.
Furthermore, as compared with streptavidin– cells, streptavidin+ 
pulmonary vascular neutrophils showed no significant change in 
expression of L-selectin and ICAM-2 but exhibited a significant 
increase in expression of β1 integrins, CD11b, ICAM-1, NE, and 
CXCR4 (Figure 8, F and G). The latter is in line with the observed 
trafficking of the streptavidin+ cells to the bone marrow. Of note, 
in IL-1β plus histamine–treated mice subjected to our labeling 
protocol, streptavidin– neutrophils in both blood and pulmonary 
vascular washout samples showed a similar phenotype to neutro-
phils acquired from unlabeled mice treated locally with just PBS, 
histamine, or IL-1β alone (Supplemental Figure 10, A and B). This 
crucial set of data precludes the possibility that in IL-1β plus his-
tamine–treated mice circulating soluble factors determine the 
phenotype of the streptavidin+ cells. Additionally, these results 
suggest that the streptavidin+ rTEM neutrophils have no impact on 
the phenotype of streptavidin– neutrophils.
In summary, we provide evidence for the ability of rTEM neu-
trophils stemming from a local hyperpermeability site to reenter the 
systemic circulation and to traffic to lungs, where they exhibit an acti-
vated proadhesive phenotype, before returning to the bone marrow.
Disseminated rTEM neutrophils localize to sites of vascular leakage 
in lungs. We have previously shown an association between rTEM 
neutrophils stemming from local inflammatory sites characterized 
by reduced junctional expression of EC JAM-C and remote organ 
injury (14, 15). We therefore hypothesized that neutrophil rTEM 
driven by local hyperpermeability could similarly cause distant 
organ damage. To investigate this notion, pulmonary vascular leak-
age resulting from stimulation of cremaster muscles was assessed 
by measuring sub-EC and extravascular accumulation of intrave-
nously administered fluorescent microspheres (26). Furthermore, 
to investigate if this response was associated with accumulation of 
rTEM neutrophils stemming from the cremaster muscle, the exper-
iments incorporated the new biotin-streptavidin labeling protocol. 
Our findings showed that mice subjected to cremaster muscle 
stimulation with IL-1β plus histamine, but neither stimulus on its 
own or local PBS, exhibited lung vascular leakage (Figure 9, A and 
B). In addition, although all reactions tested exhibited similar lev-
Figure 10. Schematic diagram of the cascade of events that link a local hyperpermeability inflammatory reaction to neutrophil rTEM and development 
of lung injury.
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the bloodstream as shown here both experimentally and math-
ematically. This hypothesis was conclusively validated through 
assessing the interstitial-to-vascular lumen distribution of exog-
enous hCXCL8 following specific genetic or pharmacological 
modulations of vascular permeability induction. Collectively, the 
findings reveal that hyperpermeability-enhancing inflammatory 
conditions can promote reverse diffusion of chemokines from 
the tissue to the vascular lumen, a phenomenon that can disrupt 
the directional motility of neutrophils through EC junctions. The 
latter was definitively illustrated in experiments where systemic 
blockade of CXCL1 prevented neutrophil rTEM in hyperperme-
ability reactions, and conversely, intravenous exogenous CXCL1 
promoted neutrophil rTEM.
The sequence of molecular and cellular events that guide neu-
trophils from the vascular lumen to the interstitial tissue is well 
established and described by the leukocyte adhesion cascade (3). 
Here, it is considered that chemokines immobilized on the lumi-
nal aspect of blood vessels trigger the local arrest of neutrophils 
(3) with sequential, compartmentalized, and locally presented 
chemotactic cues within venular walls promoting luminal-to-ab-
luminal diapedesis (6). Although glycosaminoglycans (GAGs) are 
considered to provide the principal mode of retaining chemokines 
on the luminal aspect of blood vessels, the retention of chemo-
kines within EC junctions is likely mediated by binding to the 
atypical chemokine receptor ACKR1 that is enriched at these sites 
(6, 37). Together, owing to their pivotal role in localization, reten-
tion, and/or transport of chemokines, ACKR1 and GAGs are key 
molecular players in supporting leukocyte trafficking (38, 39). In 
contrast to these physiological regulatory modes, increased vas-
cular permeability appears to account for excessive EC junctional 
motility and resultant entry of chemokines into the bloodstream. 
As such, local hyperpermeability disrupts the correct spatiotem-
poral presentation of chemotactic cues within venular walls, and 
in doing so, disrupts a phenomenon that is critical for efficient and 
unidirectional luminal-to-abluminal migration of neutrophils (6).
Although migration away from sites of inflammation and inju-
ry is now an established neutrophil behavior (34), it is highly plau-
sible that the implications of this response are different in diverse 
contexts and in varied experimental models. Most notably, neu-
trophil retrograde motility within interstitial tissues away from 
sites of sterile injury, and in some cases reentry into the blood 
circulation, is proposed as a component of inflammation resolu-
tion (24, 33, 40, 41). For example, Wang and colleagues report-
ed that neutrophils recruited to a murine thermal hepatic injury 
model contributed to revascularization of injured tissues and sub-
sequently left the injured site by reentering the local vasculature 
(24). Using an elegant mouse model that selectively expressed 
a photoactivatable GFP in neutrophils, the authors could track 
approximately 10% of the tissue infiltrated neutrophils, a proce-
dure that enabled a small number of cells to be tracked to the lungs 
and a higher number to the bone marrow. Phenotypic analysis of 
photoactivated neutrophils in these organs indicated increased 
expression of CXCR4. Based on the latter, it was concluded that 
neutrophil migration away from injured tissues is a physiological 
process that may regulate deactivation and/or reprogramming of 
neutrophils in the lungs before they are recruited to the bone mar-
row via CXCR4 for eventual clearance by apoptosis (24). The neu-
Intrigued by the lack of investigations into the potential impact 
of increased vascular permeability on neutrophil trafficking, we 
applied high-resolution confocal IVM for simultaneous analy-
sis of these phenomena. Our findings revealed that induction of 
vascular leakage does not grossly alter total tissue infiltration of 
neutrophils over several hours. However, unexpectedly, augment-
ed vascular leakage rapidly promotes a significant frequency of 
neutrophils that have initiated TEM to exhibit retrograde motility 
within EC junctions and eventually reenter the blood circulation. 
Increased microvascular permeability consistently preceded the 
occurrence of this aberrant TEM response, suggesting a causal 
link. Direct evidence for this notion was acquired through the use 
of knockin mice expressing a Y685F mutant of VE-cadherin with 
selective impaired vascular permeability induction (9) that showed 
reduced disrupted neutrophil TEM. Neutrophil reverse migration 
within EC junctions, termed “reverse TEM,” has previously been 
described by our group in relation to multiple inflammatory sce-
narios in the murine microcirculation (6, 14, 15). This response, 
which was first described in vitro for human neutrophils (32) is, 
however, one of a number of neutrophil reverse migration modes 
that to date have been reported in numerous contexts, experi-
mental models, and inflammatory conditions (23–25, 33–35). The 
wide-ranging profiles and potential implications of neutrophil ret-
rograde migration begs the need for further explorations of this 
enigmatic response in terms of its mechanisms and consequences.
In addressing the mechanisms that drive neutrophil rTEM, 
our previous works identified NE-mediated cleavage of EC junc-
tional JAM-C as a trigger of this cellular response (14, 15). Togeth-
er with in vitro studies of monocyte TEM (36), these findings 
indicated a need for EC JAM-C as a regulator of 1-way leukocyte 
trafficking through EC junctions, although the precise molecu-
lar basis of JAM-C–mediated luminal-to-abluminal neutrophil 
motility remains unclear. Of note, however, directly acting vas-
cular permeability–enhancing agents (histamine and VEGF) that 
effectively instigated neutrophil rTEM in IL-1β–stimulated tis-
sues had no impact on JAM-C expression. As an alternative mech-
anism, and based on recent findings showing the significance of 
compartmentalized directional cues in promoting neutrophil dia-
pedesis (6), we hypothesized that increased vascular permeability 
may disrupt the correct positioning of chemotactic signals within 
the venular wall niche. Focusing on CXCL1, a potent neutrophil 
chemoattractant abundantly generated within our acute inflam-
matory models, elevated plasma levels of this chemokine were 
noted in all hyperpermeability reactions tested. Intriguingly, 
these results suggested that vascular leakage can prompt the dif-
fusion of endogenously generated CXCL1 from the tissue and/or 
the venular wall into the vascular lumen. Support for this notion 
was acquired through tracking of topically applied 10-kDa dex-
tran in histamine-stimulated tissues by confocal IVM and such an 
event was predicted by mathematical modeling. Briefly, although 
under normal homeostatic conditions intact EC contacts pro-
vide a significant barrier to movement of molecules into tissues, 
this situation changes in inflammation. When vascular permea-
bility is increased, EC junctional contacts loosen, and although 
this supports increased hydraulic flux, it also causes a decrease 
in hydraulic velocity. Such a scenario can facilitate diffusion of 
a small molecule (e.g., a chemokine) from the tissue back into 
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(43). Additionally, pulmonary vasculature (but not blood) rTEM 
neutrophils showed increased expression of CXCR4, and rTEM 
neutrophils could be detected in the bone marrow 4 hours after 
their induction. These results collectively support the belief that 
neutrophils are retained within the lung vasculature in a transient 
manner during which they may be reprogrammed for homing to 
the bone marrow (24). The difference between our findings and 
those of other groups in terms of linking neutrophil rTEM to dis-
tant organ damage could lie in the nature of the reactions inves-
tigated, the type of retrograde migration being analyzed, and 
phenotype of the neutrophils stemming from the primary inflam-
matory site. Significant to our findings, acute lung injury is a 
life-threatening consequence of numerous local hyperpermeabil-
ity-inducing conditions such as trauma, and pathologies induced 
by IR injury (48, 49). Thus, we propose that activated rTEM neu-
trophils stemming from local hyperpermeability inflammatory 
sites could provide a detrimental cellular link between primary 
and secondary sites of pathological inflammation.
In summary, the present results offer a causal link between 
increased local microvascular leakage and neutrophil rTEM, an 
axis associated with development of remote organ damage. Fun-
damental to this cascade of events is the discovery that increased 
vascular leakage can induce rapid translocation of chemokines 
from the interstitium into the systemic circulation against hydrau-
lic flow, resulting in disrupted directional gradient across the 
venular wall. This response in turn drives the reentry of an acti-
vated subset of neutrophils back into the vascular lumen that can 
then contribute to development of lung injury. Collectively, our 
findings suggest that targeting excessive local microvascular per-
meability may be a plausible therapeutic strategy for protecting 
the host from secondary organ damage. Furthermore, our results 
could have implications for tumor cell intravasation and dissemi-
nation from primary sites of tumor growth that are characterized 
by leakiness of their blood vessels.
Methods
Abs. The following Abs were obtained commercially: anti-CD31 
(clone 390), PE–anti-CXCR4 (clone 2B11), anti–VE-cadherin (clone 
BV13), control anti-rabbit, anti–VE-cadherin (clone eBioBV14) mAbs 
from Thermo Fisher Scientific; PB–anti–Gr-1 (clone RB6-8C5), 
BV605–anti-CD62L (clone MEL-14), BV711–anti-CD11b (clone 
M1/70), AF488–anti-CD115 (clone AFS98), AF488–anti-CD102 
(clone 3C4 MIC2/4), PE/Dazzle594–anti-CD54 (clone YN1/1.7.4), 
PE/Cy7–anti-CD29 (clone HMβ1-1), APC-Cy7–anti-CD115 (clone 
AFS98), biotin–anti–Ly-6G (clone 1A8) mAbs from BioLegend; 
blocking anti-CXCL1 (catalog 48415) from R&D Systems; rabbit 
anti–human CXCL8 (catalog NBP2-33819) from NOVUS; anti-NE 
(catalog ab68672) from Abcam; anti–α-SMA (clone 1A4), anti-CD31 
(clone 2H8) from Sigma-Aldrich. Rabbit polyclonal anti–VE-PTP was 
generated as previously described (50). The following were gifts: 
rabbit polyclonal anti–JAM-C (clone H33; Michel Aurrand-Lions, 
INSERM, CRCM, France) and anti-MRP14 mAb (Nancy Hogg, Fran-
cis Crick Institute, London, United Kingdom).
Animals. Male WT C57BL/6 (Charles River) and LysM-EGFP-ki 
(51) mice (8–12 weeks old) were used for all studies. VEC-Y685F-ki 
mutant mice that exhibit a single point mutation in VE-cadherin were 
generated as previously described (9).
trophil reverse motility response reported in our study is distinctly 
different from that analyzed by Wang and colleagues in that it is 
restricted to EC junctions and the sub-EC space and collectively 
describes the reentry of transmigrating neutrophils back into the 
vascular compartment before the cells fully exit the venular wall. 
Although we have previously associated this response with remote 
organ damage (14, 15), our earlier works did not provide direct evi-
dence for rTEM neutrophils trafficking to secondary organs. To 
address this vital point, here we have developed an in vivo cell-la-
beling method that precisely and efficiently distinguishes luminal 
neutrophils from all cells that breach EC junctions and hence tags 
all TEM and rTEM neutrophils stemming from the tissue under 
investigation. As such, a notable strength of our method is that 
it enables analysis of the full subpopulation of rTEM neutrophils 
migrating away from an inflammatory site in terms of their fate, 
phenotype, and pathophysiological relevance.
The application of our tracking method indicated dissemina-
tion of labeled rTEM neutrophils from a local hyperpermeability 
site to the systemic circulation where they showed an activated 
phenotype (increased CD11b and ICAM-1). In the same animals, 
labeled rTEM neutrophils were detected at significantly elevated 
levels in the pulmonary vasculature with an even greater acti-
vation state, exhibiting further increased expression of CD11b 
and ICAM-1, as well as β1 integrins and NE. The latter is high-
ly indicative of degranulation contributing to some of the noted 
rTEM-neutrophil phenotypes and indeed neutrophils are known 
to express preformed stores of β2 and β1 integrins that can be 
mobilized to the cell surface during TEM (42). Certainly, there 
is ample evidence showing that engagement of neutrophils with 
EC junctional molecules can trigger signaling and transcrip-
tional events within migrating leukocytes (42), suggesting that 
rTEM and tissue-infiltrated neutrophils may exhibit similar phe-
notypes. In line with this notion, although increased expression 
of ICAM-1 on neutrophils is a slow and transcriptionally regu-
lated process (43), both tissue-infiltrated and rTEM neutrophils 
can exhibit an ICAM-1hi phenotype (14, 32, 43). Of importance, 
however, while increased expression of integrins, other granular 
proteins, and ICAM-1 on tissue-infiltrated neutrophils collective-
ly support effective breaching of venular walls, interstitial tissue 
migration, and pathogen clearance (42–46), such a phenotype 
on neutrophils that reenter the blood circulation could be high-
ly detrimental to the host. In line with this notion, we detected 
a direct association between labeled rTEM neutrophils and lung 
injury, results that support the paradigm that rTEM neutrophils 
are a subset of activated neutrophils that can contribute to turning 
a local inflammatory response into a systemic phenomenon. The 
precise mechanism through which rTEM neutrophils exert tissue 
damage remains to be elucidated. However, the strong associa-
tion of NE with the pathogenesis of numerous acute and chron-
ic lung disorders (47) suggests that increased expression of this 
serine protease on rTEM neutrophils could be a significant fac-
tor. Furthermore, elevated expression of integrins, together with 
the ICAM-1hi phenotype, may support increased aggregation and 
activation of rTEM neutrophils (e.g., degranulation and ROS gen-
eration) within small blood vessels of remote organs. Of direct 
relevance to this notion, we have previously shown that neutro-
phil ICAM-1 expression correlates with increased ROS generation 
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cence intensity of AF647-streptavidin were analyzed using the spot or 
isosurface functions of IMARIS software, respectively.
Bright-field IVM of the mouse cremaster muscle. Mice were injected 
i.s. with IL-1β (50 ng) or PBS alone for 2 hours before cremaster mus-
cle exteriorization and before the superfusion of histamine (30 μM) or 
vehicle, as described above. Leukocyte rolling, firm arrest, and extrav-
asation within 20- to 40-μm postcapillary venules were quantified by 
IVM over a 1.5-hour period using a bright-light microscope (Axioskop 
FS, Carl Zeiss), as detailed previously (44). Several vessel segments (n 
= 3–5) from multiple vessels (n = 3–5) were quantified for each animal.
Quantification of chemokine and dextran levels in tissue and plasma. 
Anesthetized (3% isoflurane) mice were subjected to cremasteric isch-
emia (40 minutes) or injected i.s. with IL-1β (50 ng) or TNF (300 ng 
R&D Systems) in 200 μL PBS. Control animals received PBS only. Two 
hours later, animals were injected with i.s. histamine (30 μM solution) 
or PBS (both in 200 μL), or i.v. VEGF (4 μg/mouse) or PBS. Cremas-
ter muscles and plasma samples (in 50 mM EDTA) were harvested 30 
minutes later. In some experiments, hCXCL8 (500 ng, Peprotech) was 
coinjected with IL-1β (50 ng) for 1 hour before the end of the in vivo 
test period (i.e., 2.5 hours). In some experiments, mice were treated i.v. 
with a blocking anti–VE-PTP Ab (200 μg) (20, 21) or rabbit IgG control 
(200 μg) 30 minutes after hCXCL8 and IL-1β injection. Other exper-
iments involved treating the mice with a blocking anti–VE-cadherin 
mAb (BV13; 100 μg) (22) or a control mAb (anti-CD31 mAb, clone 
390; 100 μg) i.s. for 3 hours followed by local injection of hCXCL8 for 
1 hour before tissue and plasma collection. Tissues were homogenized 
in PBS containing 0.1% Triton X-100 and 1% Halt Protease and Phos-
phatase Inhibitor cocktail (Thermo Fisher Scientific) and mechani-
cally dissociated using the Precellys 24 bead-beating system (Bertin 
Technologies). Levels of mCXCL1 and hCXCL8 were analyzed as per 
the manufacturer’s instructions by ELISA (R&D Systems and Thermo 
Fisher Scientific, respectively: sensitivity, 2 pg/mL). The quantity of 
chemokine detected in tissues was normalized to protein content as 
determined using a BCA assay (Thermo Fisher Scientific). Levels of 
10-kDa AF488-dextran in plasma was quantified using a BMG NOVO-
star microplate reader (BMG LABTECH).
Immunofluorescence staining and confocal analysis of tissues. Whole-
mount cremaster muscles were analyzed for expression of hCXCL8, 
JAM-C, red-(580/605)-microbeads (20 nm in diameter, 9.1 × 1013 
beads; Thermo Fisher Scientific), and AF647-streptavidin as previously 
described (6, 15). Briefly, surgically removed tissues were fixed in ice-
cold paraformaldehyde (PFA) (4% in PBS) for 45 minutes, blocked, and 
permeabilized at room temperature for 4 hours in PBS containing 25% 
FCS and 0.5% Triton X-100, and incubated overnight (anti-hCXCL8, 
anti-MRP14, anti–α-SMA, anti-CD31 staining) or 72 hours (anti–JAM-C 
staining) at 4°C with primary antibodies. Immunostained tissues were 
imaged with an inverted Zeiss 800 confocal laser-scanning microscope. 
JAM-C expression within the VE-cadherin channel was quantified as 
previously described (14, 15). For analysis of hCXCL8 localization, ECs, 
neutrophils, and pericyte isosurfaces were created based on regions 
immunostained for CD31 (CD31hi junctional and CD31dim nonjunction-
al regions), MRP14, and α-SMA, respectively. EC body and junctional 
hCXCL8 expression was quantified as MFI within these isosurfaced 
regions. The MFI of fluorescent beads present in the subendothelial 
space (<1 μm from ECs) was quantified as a measure of cremaster mus-
cle vascular leakage. An isosurface using the CD31 channel was gener-
ated to exclude fluorescent signal of beads inside the vascular lumen. 
Generation of chimeric mice. VEC-WT and VEC-Y685F mice were 
lethally irradiated with 1 dose of 9 Gy over a time period of 11 minutes 
and were subsequently injected i.v. with 1.5 × 106 to 3 × 106 bone mar-
row cells from LysM-EGFP-ki mice. Level of engraftment was evaluat-
ed 4 weeks after reconstitution and all mice showed more than 99% of 
GFP+ neutrophils with similar neutrophil counts.
Confocal IVM of the mouse cremaster muscle. Anesthetized (3% 
isoflurane) male mice received an intrascrotal (i.s.) injection of flu-
orescently labeled anti-CD31 mAb (4 μg) and/or IL-1β (50 ng, R&D 
Systems), LTB4 (300 ng, Cambridge Bioscience) to label vessels within 
the tissue and/or induce an inflammatory response, respectively. Con-
trol animals received PBS. The cremaster muscles were then prepared 
for intravital imaging 2 hours or 30 minutes after IL-1β or LTB4 admin-
istration, respectively, as described previously (14, 15). Topical applica-
tion of histamine (30 μM, Sigma-Aldrich) onto exteriorized tissues, or 
i.v. injection of VEGF (4 μg/mouse, R&D Systems) was used to induce 
vascular leakage. IR injury was induced as described previously (14, 
15). In some experiments, anti-CXCL1 mAb or control IgG2a (1 mg/
kg) and anti–VE-PTP Ab (100–200 μg) or rabbit IgG control (200 μg) 
was injected i.v. as indicated in relevant texts. In some experiments, 
recombinant mCXCL1 (50 ng, Peprotech) was injected i.v. 2 hours 
after IL-1β. To visualize vascular leakage, 75-kDa TRITC-dextran (40 
mg/kg, Sigma-Aldrich) was injected i.v. (via tail vein cannula) 1 minute 
before the superfusion of histamine, in combination with i.v. injection 
of VEGF or during the reperfusion phase of IR-stimulated tissues. In 
some experiments, 10-kDa AF488-dextran (10 μg/mL, Thermo Fish-
er Scientific) was superfused 2 minutes after i.v. injection of 75-kDa 
TRITC-dextran for 10 minutes. The superfusate was then replaced 
with either Tyrode’s solution containing histamine (30 μM) or vehicle 
control for an additional 30 minutes. To label rTEM neutrophils, bioti-
nylated anti-Ly6G mAb (2 μg) was injected i.v. 1.5 hours after IL-1β 
stimulation of tissues. Following exteriorization, the cremaster mus-
cle was superfused with AF647-streptavidin (1 μg/mL, Thermo Fisher 
Scientific) with Tyrode’s solution with or without histamine (30 μM). 
Z-stack images of postcapillary venules (20–40 μm in diameter) were 
captured using a Leica SP5 or SP8 confocal microscope incorporating 
a ×20 water-dipping objective (NA 1.0), as detailed previously (6, 14).
Quantification of neutrophil TEM, microvascular leakage, and 
streptavidin labeling. Still images and 4D live recordings were analyzed 
using IMARIS software (Bitplane). Extravascular neutrophils were 
defined as those that had fully transmigrated and passed through the 
pericyte layer, recognizable via a change in their morphology, and 
expressed as number of cells/mm3 of tissue. rTEM neutrophils were 
defined as cells that moved in an abluminal-to-luminal direction with-
in EC junctions. Normal neutrophil TEM was classified as a response 
in which the cells migrated through EC junctions only in a luminal- 
to-abluminal direction, as previously described (14, 15). Extravascu-
lar leakage was quantified by interstitial accumulation of i.v. 75-kDa 
TRITC-dextran and presented as mean fluorescence intensity (MFI) 
of indicated time points, measuring 6 to 8 regions of interest (ROI) 
in the interstitium (excluding areas exhibiting dextran-positive peri-
vascular cells) and 30 μm away from the vessel wall. These readings 
were then normalized in relation to the first 2 MFI readings obtained 
after i.v. injection of the tracer and presented as normalized MFI. Sim-
ilar analysis was conducted for the quantification of tissue levels of 
10-kDa AF488-dextran (MFI normalized to the first 2 readings after 
superfusion of the tracer). Interstitial neutrophil speed and fluores-
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each data set are provided in the figure legends. Statistical significance 
was assessed by 2-tailed Student’s t test, or 1-way or 2-way ANOVA 
followed by Bonferroni’s post hoc test. A P value less than 0.05 was 
considered significant.
Study approval. All in vivo experiments were conducted under the 
United Kingdom legislation according to the Animal Scientific Proce-
dures Act 1986, with all procedures being conducted in accordance 
with United Kingdom Home Office regulations.
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All protein expression levels were quantified from 6 to 12 images/tissue 
and expressed as MFI values of tissues stained with specific antibodies 
after subtraction of MFI values acquired from tissues stained with iso-
type control antibodies.
Analysis of blood, pulmonary vascular washout, and bone marrow neu-
trophils by flow cytometry. Mice received an i.v. injection of biotin–anti-
Ly6G mAb (2 μg) 90 minutes after stimulation of cremaster muscles 
with locally administered IL-1β (50 ng) or PBS. Mice were locally inject-
ed 30 minutes later with histamine (200 μL of 30 μM solution) or PBS in 
combination with AF647-streptavidin (400 ng). Whole blood and lung 
vascular washout were collected 120 to 240 minutes later as previously 
described (14, 15), a method that recovered approximately 50% of the 
lung pulmonary vascular neutrophils. Bone marrow was isolated from 
1 femur/animal. The samples were then analyzed using an LSR Fortes-
sa flow cytometer (Becton Dickinson) and FlowJo software (Tree Star). 
Following doublets exclusion, neutrophils from LysM-EGFP-ki and WT 
mice were gated as LysM-EGFPhiGR-1hi or GR-1hiCD115–, respectively. 
Leukocyte numbers were determined using fluorescent counting beads.
Analysis of lung vascular leakage. Pulmonary vascular leakage was 
quantified by adapting published methods (26). Briefly, mice were 
injected i.v. with crimson-(625/645)-microbeads (20 nm in diameter, 
9.1 × 1013 beads; Thermo Fisher Scientific), biotin–anti-Ly6G (2 μg), 
and AF555–anti-CD31 mAb (10 μg) in 150 μL sterile PBS, 90 minutes 
after IL-1β stimulation of cremaster muscles (50 ng in 200 μL of PBS). 
Thirty minutes later, mice were injected i.s. with histamine (200 μL 
of 30 μM solution) or PBS in combination with Atto425-streptavidin 
(400 ng, Sigma-Aldrich) for 120 minutes. At the end of the reaction, 
mice were sacrificed, the descending vena cava was clamped, and ice-
cold PFA (2% in PBS) was perfused via the right ventricle. Lung lobes 
were excised and placed on top of a cover slip and were imaged imme-
diately in situ with an inverted Zeiss 800 confocal laser-scanning 
microscope. The MFI of fluorescent beads present in the extravascular 
space (5–7 images/tissue from different lung lobes) was quantified as a 
measure of lung vascular leakage. For this purpose, an isosurface was 
generated using the anti-CD31 mAb to exclude fluorescent signal of 
beads inside the vascular lumen. To quantitatively analyze the associ-
ation between streptavidin+ neutrophils and regions of vascular leak-
age, we arbitrarily defined streptavidin+ neutrophil regions as areas 
that expressed at least 1 streptavidin+ neutrophil within a perimeter of 
60 μm. Control areas within the same image were defined as similarly 
sized regions that were devoid of streptavidin+ neutrophils.
Statistics. Data analysis was performed using Prism 6 (GraphPad 
Software). Results are expressed as mean ± SEM and the n values for 
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